menu
    • menu

    Company profile for Kirin Holdings

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Kirin Holdings Company, Limited is an international company that operates in the Food & Beverages domain (Food & Beverages businesses), Pharmaceuticals domain (Pharmaceuticals businesses), and Health Science domain (Health Science business), both in Japan and across the globe. Kirin Holdings can trace its roots to Japan Brewery which was established in 1885. Japan Brewery became Kirin Brewery in 1907. Since then, the compan...
    Kirin Holdings Company, Limited is an international company that operates in the Food & Beverages domain (Food & Beverages businesses), Pharmaceuticals domain (Pharmaceuticals businesses), and Health Science domain (Health Science business), both in Japan and across the globe. Kirin Holdings can trace its roots to Japan Brewery which was established in 1885. Japan Brewery became Kirin Brewery in 1907. Since then, the company expanded its business with fermentation and biotechnology as its core technologies, and entered the pharmaceutical business in the 1980s, all of which continue to be global growth centers.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Kirin Holdingsjapan Flag
    Country
    Country
    Japan
    Address
    Address
    Nakano City, Tokyo
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.kirinholdings.com/en/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/kirin-holdings/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Kirin Enhances Heat, Drought Tolerance In Hop Seedlings
    Kirin Enhances Heat, Drought Tolerance In Hop Seedlings

    25 Sep 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250924957521/en/KIRIN-Develops-Technology-to-Enhance-Heat-and-Drought-Tolerance-in-Hop-Seedlings-Contributing-to-a-Sustainable-Supply-of-Beer-Ingredients-Amid-Climate-Change

    BUSINESSWIRE
    25 Sep 2025
    Share Share
    Japan's Kirin clinched Fancl takeover to propel health pivot, president says
    Japan's Kirin clinched Fancl takeover to propel health pivot, president says

    29 Aug 2024

    // REUTERS

    https://www.reuters.com/business/healthcare-pharmaceuticals/japans-kirin-clinched-fancl-takeover-propel-health-pivot-president-says-2024-08-29/

    REUTERS
    29 Aug 2024
    Share Share
    Kirin Holdings Commences Tender Offer To Make FANCL A Wholly-Owned Subsidiary
    Kirin Holdings Commences Tender Offer To Make FANCL A Wholly-Owned Subsidiary

    14 Jun 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240614754306/en

    BUSINESSWIRE
    14 Jun 2024
    Share Share
    LC-Plasma-based Vaccine Research Selected for SCARDA Project
    LC-Plasma-based Vaccine Research Selected for SCARDA Project

    07 May 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240507111790/en

    BUSINESSWIRE
    07 May 2024
    Share Share
    Norges Bank Terminates Its Observation On Kirin Holdings
    Norges Bank Terminates Its Observation On Kirin Holdings

    23 Mar 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230322005808/en

    BUSINESSWIRE
    23 Mar 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search